ClearBridge Investments’s Cocrystal Pharma COCP Stock Holding History

ClearBridge Investments’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14	Closed	-$1K	–	1132
2018 Q2	$1K	Hold	14	–	–	﹤0.01%	1122
2018 Q1	$1K	Buy	+14	New	+$874	﹤0.01%	1124

Other funds holding COCP

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearBridge Investments's COCP Position: Q3 2018 in Review

ClearBridge Investments sold out of Cocrystal Pharma (COCP) in Q3 2018, closing a stake of 14 shares — an estimated $1K sold.

ClearBridge Investments first reported a position in COCP in Q1 2018 and held it in 2 quarters. The position peaked at $1K in Q2 2018. 24 funds tracked by Wall St. Rank hold COCP as of Q3 2018.

ClearBridge Investments reported no remaining Cocrystal Pharma position as of Q3 2018 after selling out during the quarter.
ClearBridge Investments sold 14 Cocrystal Pharma shares in Q3 2018, an estimated $1K.
ClearBridge Investments first reported a position in Cocrystal Pharma in Q1 2018 and held it in 2 quarters.
ClearBridge Investments's Cocrystal Pharma position peaked at $1K in Q2 2018.
24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2018.

Based on ClearBridge Investments's 13F filing for Q3 2018, filed 14 Nov 2018.